Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS03 - Symposium by Takeda Oncology: Current Treatment Landscape And Unmet Needs In ALK+ NSCLC (Not IASLC CME Accredited)
- 13:00 - 14:30
- 9/07/2019
- Location: Copenhagen (1980)
- Type: Industry Symposia & Workshops
- Track:
-
+
IBS05 - Lung Cancer Genetics to Beat Lung Cancer (Ticketed Session)
- 07:00 - 08:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Biology
-
+
IBS05.01 - KRAS Mutant Lung Cancer
07:00 - 07:20 | Presenter: Pasi A Jänne
- Abstract
Loading...
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading...
-
+
MA09 - EGFR & MET
- 15:15 - 16:45
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Jordi Remon, Juergen Wolf
-
+
MA09.02 - In Vivo, Ex Vivo and Early Clinical Activity of EGFR Monoclonal Antibody and Osimertinib in EGFR Exon 20 Insertion NSCLC
15:20 - 15:25 | Presenter: Jonathan Wesley Riess | Author(s): Nicolas Floch, Philip C. Mack, Matthew J. Martin, Daniel Vang, Paul D. Smith, Darren Cross, Mingshan Cheng, James Keck, Susan Groshen, Michael Rabin, Sukhmani Padda, Geoffrey R Oxnard, Jacob Sands, Kavitha Ramchandran, Mariana Koczywas, Jeffrey A. Moscow, Pasi A Jänne, Primo N. Lara, Edward Newman, David R Gandara
- Abstract
Loading... -
+
MA09.05 - Genomic Correlates of Differential Response to EGFR-Directed Tyrosine Kinase Inhibitors
15:45 - 15:50 | Presenter: Natalie Vokes | Author(s): Tom Nguyen, Christine A Lydon, Emily Chambers, Lynette M Sholl, Mizuki Nishino, Eliezer M Van Allen, Pasi A Jänne
- Abstract
Loading... -
+
MA09.11 - Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer
16:25 - 16:30 | Presenter: Gonzalo Recondo Jr. | Author(s): Magda Bahcall, Lynette M Sholl, Giulia Constanza Leonardi, Biagio Ricciuti, Tom Nguyen, Deepti Venkatraman, Giuseppe Lamberti, Renato Umeton, Pasi A Jänne, Mark Awad
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-127 - Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Joel W Neal, D. Ross Camidge, Alexander Spira, Zosia Piotrowska, Leora Horn, Daniel B Costa, Anne Tsao, Jyoti D Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, HOWARD WEST, Sylvie Vincent, Jian Zhu, Shu Jin, Steven Zhang, Shuanglian Li, Pasi A Jänne
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-29 - Disrupting the Paradigm: Partnering with Oncogene-Focused Patient Groups to Propel Research
09:45 - 09:45 | Presenter: Janet Freeman-Daily | Author(s): Bonnie Addario, Colin Barton, Upal Basu Roy, Shelley B Blam, Ivy Elkins, Jill Feldman, Anita Figueras, Robert Hanlon, Marcia Karen Horn, Pasi A Jänne, Christine M Lovly, Amy Moore, Terry L Ng, Alicia Sable-Hunt, Sandra Shaw, Robert C. Doebele
- Abstract
Loading...
-
+
OA07 - Precision Medicine Involves Biology and Patients
- 11:00 - 12:30
- 9/09/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Advanced NSCLC
- Moderators:Silvia Novello, Fabrice Barlesi
-
+
OA07.01 - Osimertinib Plus Platinum/Pemetrexed in Newly-Diagnosed Advanced EGFRm-Positive NSCLC; The Phase 3 FLAURA2 Study
11:00 - 11:10 | Presenter: Pasi A Jänne | Author(s): David Planchard, Paul Howarth, Alexander Todd, Kunihiko Kobayashi
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-31 - Chemokine Receptor CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC
10:15 - 10:15 | Presenter: Jeffrey Becker | Author(s): Yandi Gao, Margaret Soucheray, Inés Pulido, Eiki Kikuchi, María L. Rodríguez, Rutu Gandhi, Aranzazu Lafuente-Sánchis, Miguel Aupi, Javier Alcacer Fernandez-Coronado, Paloma Martín, Antonio Cremades, José M. Galbis-Caravajal, Javier Alcacer, Camilla L. Christensen, Patricia Simms, Ashley Hess, Hajime Asahina, Michael P Kahle, Fátima Al-Shahrour, Jeffrey Allen Borgia, Agustin Lahoz, Amelia Insa, Oscar Juan, Pasi A Jänne, Kwok-Kin Wong, Julian Carretero, Takeshi Shimamura
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.06 - Preliminary Phase 1 Results of U3-1402 — A Novel HER3-Targeted Antibody–Drug Conjugate—in EGFR TKI-Resistant, EGFR-Mutant NSCLC
15:05 - 15:10 | Presenter: Helena A Yu | Author(s): Melissa Johnson, Conor E Steuer, Michele Vigliotti, Shuquan Chen, Yasuki Kamai, Channing Yu, Pasi A Jänne
- Abstract
Loading...